MicroRNAs and their target gene networks in breast cancer

被引:362
作者
O'Day, Elizabeth
Lal, Ashish [1 ]
机构
[1] Harvard Univ, Childrens Hosp Boston, Program Cellular & Mol Med, Immune Dis Inst,Sch Med, Boston, MA 02115 USA
来源
BREAST CANCER RESEARCH | 2010年 / 12卷 / 02期
关键词
TRANSCRIPTIONAL REPRESSORS ZEB1; CELL-PROLIFERATION; E-CADHERIN; TUMOR-SUPPRESSOR; MIR-200; FAMILY; MESSENGER-RNA; MESENCHYMAL TRANSITION; CAENORHABDITIS-ELEGANS; EPITHELIAL PHENOTYPE; PROTEIN-SYNTHESIS;
D O I
10.1186/bcr2484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are a major class of small endogenous RNA molecules that post-transcriptionally inhibit gene expression. Many miRNAs have been implicated in several human cancers, including breast cancer. Here we describe the association between altered miRNA signatures and breast cancer tumorigenesis and metastasis. The loss of several tumor suppressor miRNAs (miR-206, miR-17-5p, miR-125a, miR-125b, miR-200, let-7, miR-34 and miR-31) and the overexpression of certain oncogenic miRNAs (miR-21, miR-155, miR-10b, miR-373 and miR-520c) have been observed in many breast cancers. The gene networks orchestrated by these miRNAs are still largely unknown, although key targets have been identified that may contribute to the disease phenotype. Here we report how the observed perturbations in miRNA expression profiles may lead to disruption of key pathways involved in breast cancer.
引用
收藏
页数:10
相关论文
共 79 条
[1]   miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels [J].
Abdelmohsen, Kotb ;
Srikantan, Subramanya ;
Kuwano, Yuki ;
Gorospe, Myriam .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) :20297-20302
[2]   The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines [J].
Adams, Brian D. ;
Furneaux, Henry ;
White, Bruce A. .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (05) :1132-1147
[3]   The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity [J].
Aigner, K. ;
Dampier, B. ;
Descovich, L. ;
Mikula, M. ;
Sultan, A. ;
Schreiber, M. ;
Mikulits, W. ;
Brabletz, T. ;
Strand, D. ;
Obrist, P. ;
Sommergruber, W. ;
Schweifer, N. ;
Wernitznig, A. ;
Beug, H. ;
Foisner, R. ;
Eger, A. .
ONCOGENE, 2007, 26 (49) :6979-6988
[4]   The impact of microRNAs on protein output [J].
Baek, Daehyun ;
Villen, Judit ;
Shin, Chanseok ;
Camargo, Fernando D. ;
Gygi, Steven P. ;
Bartel, David P. .
NATURE, 2008, 455 (7209) :64-U38
[5]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[6]   Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 [J].
Baselga, Jose ;
Swain, Sandra M. .
NATURE REVIEWS CANCER, 2009, 9 (07) :463-475
[7]   MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype [J].
Blenkiron, Cherie ;
Goldstein, Leonard D. ;
Thorne, Natalie P. ;
Spiteri, Inmaculada ;
Chin, Suet-Feung ;
Dunning, Mark J. ;
Barbosa-Morais, Nuno L. ;
Teschendorff, Andrew E. ;
Green, Andrew R. ;
Ellis, Ian O. ;
Tavare, Simon ;
Caldas, Carlos ;
Miska, Eric A. .
GENOME BIOLOGY, 2007, 8 (10)
[8]   RNA polymerase III transcribes human microRNAs [J].
Borchert, Glen M. ;
Lanier, William ;
Davidson, Beverly L. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (12) :1097-1101
[9]   bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila [J].
Brennecke, J ;
Hipfner, DR ;
Stark, A ;
Russell, RB ;
Cohen, SM .
CELL, 2003, 113 (01) :25-36
[10]   A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801